Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 21.2% on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. 283,894 shares changed hands during trading, a decline of 47% from the average session volume of 537,850 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The stock has a fifty day moving average of C$0.10 and a 200-day moving average of C$0.07. The firm has a market capitalization of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- P/E Ratio Calculation: How to Assess Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
